RegIntel Platform Goes Live with Multi-Country Regulatory Filing Support
The RegIntel platform provides real-time regulatory intelligence for pharma companies navigating NMPA, PMDA, and HSA filings.
HealthTech Nexus is proud to announce the general availability of RegIntel, our regulatory intelligence and filing management platform. RegIntel now supports regulatory pathways across China (NMPA), Japan (PMDA), and Singapore/ASEAN (HSA), with FDA and EMA coverage planned for Q3 2026.
Related Articles
HealthTech Nexus Closes Seed Round to Accelerate AI Platform Development
Funding will be deployed to expand Bio R&D and RegIntel platform capabilities, with a focus on expanding into China, Japan, and Southeast Asian markets.
HealthTech Nexus Partners with Leading Singapore Biomedical Research Institute
Partnership will pilot the Bio R&D data platform for translational research, covering clinical data management and AI-assisted drug target identification.
Asia-Pacific Pharma Digitalization: 5 Trends Shaping 2026
From AI-accelerated regulatory submissions to GMP digital twins — we break down the key trends transforming life sciences operations across Asia.